|
POLR2I expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.41710000001183E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.05079999995961E-06 |
| Normal-vs-Stage2 |
3.351200E-01 |
| Normal-vs-Stage3 |
1.462500E-02 |
| Normal-vs-Stage4 |
5.776500E-03 |
| Stage1-vs-Stage2 |
1.532770E-01 |
| Stage1-vs-Stage3 |
2.604200E-01 |
| Stage1-vs-Stage4 |
6.436000E-01 |
| Stage2-vs-Stage3 |
4.050200E-01 |
| Stage2-vs-Stage4 |
8.412100E-02 |
| Stage3-vs-Stage4 |
1.710370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64639999999938E-06 |
| Normal-vs-AfricanAmerican |
4.360300E-03 |
| Normal-vs-Asian |
3.184600E-01 |
| Caucasian-vs-AfricanAmerican |
8.816000E-01 |
| Caucasian-vs-Asian |
7.214200E-01 |
| AfricanAmerican-vs-Asian |
7.508200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.57750000001822E-06 |
| Normal-vs-Female |
1.978300E-03 |
| Male-vs-Female |
6.770200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.037410E-03 |
| Normal-vs-Extreme_Weight |
7.58240000009458E-07 |
| Normal-vs-Obese |
7.753100E-04 |
| Normal-vs-Extreme_Obese |
1.267640E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.381400E-01 |
| Normal_Weight-vs-Obese |
3.901200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.278400E-01 |
| Extreme_Weight-vs-Obese |
4.583800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.198800E-01 |
| Obese-vs-Extreme_Obese |
8.309200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.206300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.376080E-04 |
| Normal-vs-Age(61-80Yrs) |
1.58849999999378E-05 |
| Normal-vs-Age(81-100Yrs) |
2.241200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.631000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.738600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.723800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.001400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.883000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.467000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.73020000735636E-09 |
| Normal-VS-Type2 PRCC |
1.073830E-01 |
| Normal-VS-KIRP CIMP |
6.152600E-01 |
| Normal-VS-Unclassified PRCC |
9.057700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.168700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.819800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.657600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.771600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.810800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.972600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.444200E-04 |
| Normal-vs-N1 |
8.815500E-03 |
| Normal-vs-N2 |
4.624200E-01 |
| N0-vs-N1 |
2.845600E-01 |
| N0-vs-N2 |
9.239200E-01 |
| N1-vs-N2 |
8.306800E-01 |
|
|
